LabRoots Educational Webinar Discusses Fecal Lactoferrin Measurements in Clinical Practice

Share Article

Through this webinar, which LabRoots will host May 3, participants will be able to identify scenarios in which fecal lactoferrin testing may aid in diagnosis.

Paul Rufo, MD, MMSc Assistant Professor of Pediatrics, Harvard Medical School and Program Director, HMS Fellowship in Pediatric Gastroenterology, Boston Children's Hospital

Intestinal inflammation is a hallmark of inflammatory bowel diseases (IBD), including ulcerative colitis and Crohn's disease. These chronic GI illnesses affect upwards of 3 million people in the United States.

Many of the symptoms in patients with IBD overlap with those observed in patients with irritable bowel syndrome (IBS), a discrete and likely pathogenically pleomorphic gastrointestinal illness. Nonetheless, there is a premium on distinguishing between IBD and IBS as their treatment differs significantly.

Fecal lactoferrin testing is a non-invasive metric that can be used to help differentiate IBD and IBS patients presenting with non-specific gastrointestinal symptoms. Previous data have demonstrated that fecal lactoferrin levels may also be useful in tracking disease activity or assessing response to therapy.

In this webinar, participants will learn to recognize when fecal lactoferrin levels may be useful in tracking disease activity or assessing response to therapy. They will also learn how to use fecal lactoferrin biomarkers as a non-invasive first-step diagnostic tool to identify when scoping is most appropriate, especially in certain patient populations such as pediatrics.

The speaker for this event will be Dr. Paul Rufo, an assistant professor of pediatrics at Harvard Medical School, as well as the program director of the HMS Fellowship in Pediatric Gastroenterology at Boston Children's Hospital. He received his medical degree from the University of Massachusetts Medical School and an MMSc degree from Harvard Medical School. His research is focused on the development of new modalities for use in the diagnosis and interval assessment of children and adults with IBD.

LabRoots will host this event May 3rd, 2018; the webinar will start at 8:00 a.m. PDT, 11:00 a.m. EDT. To learn more about this event, the continuing education credits offered, or to register for free, click here.

About LabRoots
LabRoots is the leading scientific social networking website, which provides daily scientific trending news and science-themed apparel, as well as produces educational virtual events and webinars, on the latest discoveries and advancements in science. Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Founded in 2008, LabRoots emphasizes digital innovation in scientific collaboration and learning, and is a primary source for current scientific news, webinars, virtual conferences, and more. LabRoots has grown into the world’s largest series of virtual events within the Life Sciences and Clinical Diagnostics community.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Karen Sorenson
LabRoots, Inc.
+1 (619) 861-0590
Email >
Visit website